{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:33:12Z","timestamp":1793057592033,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41429-026-00957-5","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:57:28Z","timestamp":1788335848000},"page":"766-774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CSA-13 treatment in a murine model of Pseudomonas pneumonia-induced sepsis and its effects on renal injury, inflammation, and glycocalyx derangement"],"prefix":"10.1038","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4134-3136","authenticated-orcid":false,"given":"Ugur","family":"Aksu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1202-1266","authenticated-orcid":false,"given":"Cagla","family":"Bozkurt-Guzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8983-9675","authenticated-orcid":false,"given":"Gonca","family":"Erkose-Genc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4899-9146","authenticated-orcid":false,"given":"Olgu Enis","family":"Tok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3380-1480","authenticated-orcid":false,"given":"Mukaddes","family":"Esrefoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9992-7225","authenticated-orcid":false,"given":"Ozlem","family":"Oyardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4642-6109","authenticated-orcid":false,"given":"Paul B.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"957_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00063-023-01093-w","volume":"118","author":"A Guzzardella","year":"2023","unstructured":"Guzzardella A, Motos A, Vallverd\u00fa J, Torres A. Corticosteroids in sepsis and community-acquired pneumonia. Med Klin Intensivmed Notfmed. 2023;118:86\u201392. https:\/\/doi.org\/10.1007\/s00063-023-01093-w.","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"957_CR2","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3389\/fimmu.2020.01722","volume":"11","author":"V Kumar","year":"2020","unstructured":"Kumar V. Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury. Front Immunol. 2020;11:1722 https:\/\/doi.org\/10.3389\/fimmu.2020.01722.","journal-title":"Front Immunol"},{"key":"957_CR3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.bjid.2020.09.004","volume":"24","author":"G Sygitowicz","year":"2021","unstructured":"Sygitowicz G, Sitkiewicz D. Molecular mechanisms of organ damage in sepsis: an overview. Braz J Infect Dis. 2021;24:552\u201360. https:\/\/doi.org\/10.1016\/j.bjid.2020.09.004.","journal-title":"Braz J Infect Dis"},{"key":"957_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/cc13775","volume":"18","author":"AA Kalanuria","year":"2014","unstructured":"Kalanuria AA, Zai W, Mirski M. Ventilator-associated pneumonia in the ICU. Crit Care. 2014;18:208. https:\/\/doi.org\/10.1186\/cc13775.","journal-title":"Crit Care"},{"key":"957_CR5","doi-asserted-by":"publisher","first-page":"9159","DOI":"10.3390\/ijms23169159","volume":"23","author":"YM Chang","year":"2022","unstructured":"Chang YM, Chou YT, Kan WC, Shiao CC. Sepsis and acute kidney injury: a review focusing on the bidirectional interplay. Int J Mol Sci. 2022;23:9159 https:\/\/doi.org\/10.3390\/ijms23169159.","journal-title":"Int J Mol Sci"},{"key":"957_CR6","first-page":"125","volume":"40","author":"S Dirkes","year":"2013","unstructured":"Dirkes S. Sepsis and inflammation: impact on acute kidney injury. Nephrol Nurs J. 2013;40:125\u201332.","journal-title":"Nephrol Nurs J"},{"key":"957_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000329237","volume":"174","author":"K Singbartl","year":"2011","unstructured":"Singbartl K. Renal-pulmonary crosstalk. Contrib Nephrol. 2011;174:65\u201370. https:\/\/doi.org\/10.1159\/000329237.","journal-title":"Contrib Nephrol"},{"key":"957_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12882-024-03551-9","volume":"25","author":"DH Wang","year":"2024","unstructured":"Wang DH, Zhao JC, Xi XM, Zheng Y, Li WX. Attributable mortality of acute kidney injury among critically ill patients with sepsis: a multicenter, retrospective cohort study. BMC Nephrol. 2024;25:125 https:\/\/doi.org\/10.1186\/s12882-024-03551-9.","journal-title":"BMC Nephrol"},{"key":"957_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.nefroe.2024.11.010","volume":"44","author":"L Gonz\u00e1lez-Lafuente","year":"2024","unstructured":"Gonz\u00e1lez-Lafuente L, Mercado-Garc\u00eda E, V\u00e1zquez-S\u00e1nchez S, Gonz\u00e1lez-Moreno D, Bosc\u00e1 L, Fern\u00e1ndez-Velasco M, et al. Interleukin-6 as a prognostic marker in acute kidney injury and its klotho-dependent regulation. Nefrologia. 2024;44:818\u201329. https:\/\/doi.org\/10.1016\/j.nefroe.2024.11.010.","journal-title":"Nefrologia"},{"key":"957_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fimmu.2017.00405","volume":"8","author":"H Su","year":"2017","unstructured":"Su H, Lei CT, Zhang C. Interleukin-6 signaling pathway and its role in kidney disease: an update. Front Immunol. 2017;8:405 https:\/\/doi.org\/10.3389\/fimmu.2017.00405.","journal-title":"Front Immunol"},{"key":"957_CR11","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1007\/s00134-020-06153-9","volume":"11","author":"R Arrestier","year":"2022","unstructured":"Arrestier R, Gendreau S, Mokrani D, Darmon M, Azoulay E, Zafrani L. Acute kidney injury in critically ill COVID-19 patients. J Clin Med. 2022;11:2029 https:\/\/doi.org\/10.1007\/s00134-020-06153-9.","journal-title":"J Clin Med"},{"key":"957_CR12","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1164\/ajrccm.156.4.9610002","volume":"156","author":"MJM Bonten","year":"1997","unstructured":"Bonten MJM, Froon AHM, Gaillard CA, Greve JW, Leeuw PW, Drent M, et al. The systemic inflammatory response in the development of ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997;156:1105\u201313. https:\/\/doi.org\/10.1164\/ajrccm.156.4.9610002.","journal-title":"Am J Respir Crit Care Med"},{"key":"957_CR13","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","volume":"78","author":"A Ciesielska","year":"2021","unstructured":"Ciesielska A, Matyjek M, Kwiatkowska K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci. 2021;78:1233\u201361. https:\/\/doi.org\/10.1007\/s00018-020-03656-y.","journal-title":"Cell Mol Life Sci"},{"key":"957_CR14","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1007\/s12272-016-0806-9","volume":"39","author":"A Achek","year":"2016","unstructured":"Achek A, Yesudhas D, Choi S. Toll-like receptors: promising therapeutic targets for inflammatory diseases. Arch Pharm Res. 2016;39:1032\u201349. https:\/\/doi.org\/10.1007\/s12272-016-0806-9.","journal-title":"Arch Pharm Res"},{"key":"957_CR15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12272-011-0318-6","volume":"34","author":"JH Park","year":"2011","unstructured":"Park JH, Hwang IC, Ha N, Lee S, Kim JM, Lee SS, et al. Effects of the anti-sepsis drug CKD-712 on mortality, inflammation, and organ injuries in rodent sepsis models. Arch Pharm Res. 2011;34:485\u201394. https:\/\/doi.org\/10.1007\/s12272-011-0318-6.","journal-title":"Arch Pharm Res"},{"key":"957_CR16","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1007\/s00431-021-04076-1","volume":"180","author":"R Vijay","year":"2021","unstructured":"Vijay R, Lal BB, Sood V, Khanna R, Alam S. Cystatin C: best biomarker for acute kidney injury and estimation of glomerular filtration rate in childhood cirrhosis. Eur J Pediatr. 2021;180:3287\u201395. https:\/\/doi.org\/10.1007\/s00431-021-04076-1.","journal-title":"Eur J Pediatr"},{"key":"957_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.751299","volume":"8","author":"HS Al-Amodi","year":"2021","unstructured":"Al-Amodi HS, Abdelsattar S, Kasemy ZA, Bedair HM, Elbarbary HS, Kamel HF. Potential value of TNF-\u03b1 (\u2013376 G\/A) polymorphism and cystatin C (CysC) in the diagnosis of sepsis-associated acute kidney injury (S-AKI) and prediction of mortality in critically ill patients. Front Mol Biosci. 2021;8:751299. https:\/\/doi.org\/10.3389\/fmolb.2021.751299.","journal-title":"Front Mol Biosci"},{"key":"957_CR18","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1161\/01.ATV.0000085630.24353.3D","volume":"23","author":"AA Constantinescu","year":"2003","unstructured":"Constantinescu AA, Vink H, Spaan JA. Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler Thromb Vasc Biol. 2003;23:1541\u201347. https:\/\/doi.org\/10.1161\/01.ATV.0000085630.24353.3D.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"957_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12882-020-02219-4","volume":"22","author":"H Liew","year":"2021","unstructured":"Liew H, Roberts MA, Pope A, McMahon LP. Endothelial glycocalyx damage in kidney disease correlates with uraemic toxins and endothelial dysfunction. BMC Nephrol. 2021;22:63 https:\/\/doi.org\/10.1186\/s12882-020-02219-4.","journal-title":"BMC Nephrol"},{"key":"957_CR20","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.ekir.2023.08.031","volume":"8","author":"RE Campbell","year":"2023","unstructured":"Campbell RE, Chen CH, Edelstein CL. Overview of antibiotic-induced nephrotoxicity. Kidney Int Rep. 2023;8:2211\u201325. https:\/\/doi.org\/10.1016\/j.ekir.2023.08.031.","journal-title":"Kidney Int Rep"},{"key":"957_CR21","doi-asserted-by":"publisher","first-page":"k4891","DOI":"10.1136\/bmj.k4891","volume":"364","author":"JT Poston","year":"2019","unstructured":"Poston JT, Koyner JL. Sepsis-associated acute kidney injury. Bmj. 2019;364:k4891 https:\/\/doi.org\/10.1136\/bmj.k4891.","journal-title":"Bmj"},{"key":"957_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccrj.2025.100148","volume":"27","author":"EJ See","year":"2025","unstructured":"See EJ, Chawla LS. Redefining the modern paradigm of vasopressor therapy for vasodilatory shock. Crit Care Resusc. 2025;27:100148. https:\/\/doi.org\/10.1016\/j.ccrj.2025.100148.","journal-title":"Crit Care Resusc"},{"key":"957_CR23","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.3390\/microorganisms11092231","volume":"11","author":"S Kamath","year":"2023","unstructured":"Kamath S, Hammad Altaq H, Abdo T. Management of sepsis and septic shock: what have we learned in the last two decades? Microorganisms. 2023;11:2231 https:\/\/doi.org\/10.3390\/microorganisms11092231.","journal-title":"Microorganisms"},{"key":"957_CR24","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02726-21","volume":"13","author":"G Mitchell","year":"2022","unstructured":"Mitchell G, Silvis MR, Talkington KC, Budzik JM, Dodd CE, Paluba JM, et al. Ceragenins and antimicrobial peptides kill bacteria through distinct mechanisms. mBio. 2022;13:e02726-21. https:\/\/doi.org\/10.1128\/mbio.02726-21.","journal-title":"mBio"},{"key":"957_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00284-023-03443-5","volume":"80","author":"FN Yilmaz","year":"2023","unstructured":"Yilmaz FN, \u00d6ks\u00fcz L, Demir ES, Dosler S, Savage P, Bozkurt Guzel C. Efficacy of ceragenins alone and in combinations with antibiotics against multidrug-resistant gram-negative pathogens from bloodstream infections. Curr Microbiol. 2023;80:327 https:\/\/doi.org\/10.1007\/s00284-023-03443-5.","journal-title":"Curr Microbiol"},{"key":"957_CR26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/jac\/dkm218","volume":"60","author":"R Bucki","year":"2007","unstructured":"Bucki R, Sostarecz AG, Byfield FJ, Savage P, Janmey A. Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA of F-actin, and its activity in cystic fibrosis sputum. J Antimicrob Chemother. 2007;60:535\u201345. https:\/\/doi.org\/10.1093\/jac\/dkm218.","journal-title":"J Antimicrob Chemother"},{"key":"957_CR27","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.2147\/IDR.S338827","volume":"14","author":"P Paprocka","year":"2021","unstructured":"Paprocka P, Durna\u015b B, Ma\u0144kowska A, Sk\u0142odowski K, Kr\u00f3l G, Zakrzewska M, et al. New \u03b2-lactam antibiotics and ceragenins\u2014a study to assess their potential in treatment of infections caused by multidrug-resistant strains of Pseudomonas aeruginosa. Infect Drug Resist. 2021;14:5681\u201398. https:\/\/doi.org\/10.2147\/IDR.S338827.","journal-title":"Infect Drug Resist"},{"key":"957_CR28","unstructured":"CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Ninth Edition. M07-A9. Wayne, PA: Clinical and Laboratory Standards Institute."},{"key":"957_CR29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1128\/CVI.00419-07","volume":"15","author":"JM Scarff","year":"2008","unstructured":"Scarff JM, Goldberg JB. Vaccination against Pseudomonas aeruginosa pneumonia in immunocompromised mice. Clin Vaccin Immunol. 2008;15:367\u201375. https:\/\/doi.org\/10.1128\/CVI.00419-07.","journal-title":"Clin Vaccin Immunol"},{"key":"957_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4172\/2472-1212.1000141","volume":"3","author":"MM Hashemi","year":"2017","unstructured":"Hashemi MM, Holden BS, Durnas B, Bucki R, Savage P. Ceragenins as mimics of endogenous antimicrobial peptides. J Antimicrob Agents. 2017;3:141 https:\/\/doi.org\/10.4172\/2472-1212.1000141.","journal-title":"J Antimicrob Agents"},{"key":"957_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16753-z","volume":"7","author":"C Xu","year":"2017","unstructured":"Xu C, Ghali S, Wang J, Shih DQ, Ortiz C, Mussatto CC, et al. CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor-like-1-mediated HMG-CoA reductase pathway. Sci Rep. 2017;7:16351. https:\/\/doi.org\/10.1038\/s41598-017-16753-z.","journal-title":"Sci Rep"},{"key":"957_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2180-10-9","volume":"10","author":"L Peluso","year":"2010","unstructured":"Peluso L, De Luca C, Bozza S, Leonardi A, Giovannini G, Lavorgna A, et al. Protection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization. BMC Microbiol. 2010;10:9 https:\/\/doi.org\/10.1186\/1471-2180-10-9.","journal-title":"BMC Microbiol"},{"key":"957_CR33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2406234121","volume":"121","author":"RP Duncan","year":"2024","unstructured":"Duncan RP, Moustafa DA, Lewin GR, Diggle FL, Bomberger JM, Whiteley M, et al. Improvement of a mouse infection model to capture Pseudomonas aeruginosa chronic physiology in cystic fibrosis. PNAS. 2024;121:e2406234121. https:\/\/doi.org\/10.1073\/pnas.2406234121.","journal-title":"PNAS"},{"key":"957_CR34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/MNH.0b013e32834b8850","volume":"20","author":"LA Inker","year":"2011","unstructured":"Inker LA, Okparavero A. Cystatin C as a marker of glomerular filtration rate: prospects and limitations. Curr Opin Nephrol Hypertens. 2011;20:631\u20139. https:\/\/doi.org\/10.1097\/MNH.0b013e32834b8850.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"957_CR35","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.3390\/diagnostics14242845","volume":"14","author":"D Kounatidis","year":"2024","unstructured":"Kounatidis D, Tzivaki I, Daskalopoulou S, Daskou A, Adamou A, Rigatou A, et al. Sepsis-associated acute kidney injury: What\u2019s new regarding its diagnostics and therapeutics? Diagnostics. 2024;14:2845 https:\/\/doi.org\/10.3390\/diagnostics14242845.","journal-title":"Diagnostics"},{"key":"957_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2292-6","volume":"23","author":"R Uchimido","year":"2019","unstructured":"Uchimido R, Schmidt EP, Shapiro NI. The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Crit Care. 2019;23:16. https:\/\/doi.org\/10.1186\/s13054-018-2292-6.","journal-title":"Crit Care"},{"key":"957_CR37","doi-asserted-by":"publisher","first-page":"6274","DOI":"10.1128\/AAC.00653-15","volume":"59","author":"R Bucki","year":"2015","unstructured":"Bucki R, Niemirowicz K, Wnorowska U, Byfield FJ, Piktel E, W\u0105tek M, et al. Bactericidal activity of ceragenin CSA-13 in cell culture and in an animal model of peritoneal infection. Antimicrob Agents Chemother. 2015;59:6274\u201382. https:\/\/doi.org\/10.1128\/AAC.00653-15.","journal-title":"Antimicrob Agents Chemother"},{"key":"957_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23281-y","volume":"12","author":"U Wnorowska","year":"2022","unstructured":"Wnorowska U, Piktel E, Deptu\u0142a P, Wollny T, Kr\u00f3l G, G\u0142uszek K, et al. Ceragenin CSA-13 displays high antibacterial efficiency in a mouse model of urinary tract infection. Sci Rep. 2022;12:19164. https:\/\/doi.org\/10.1038\/s41598-022-23281-y.","journal-title":"Sci Rep"},{"key":"957_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1471-2369-14-133","volume":"14","author":"SS Han","year":"2013","unstructured":"Han SS, Kim S, Ahn SY, Lee J, Kim DK, Chin HJ, et al. Duration of acute kidney injury and mortality in critically ill patients: a retrospective observational study. BMC Nephrol. 2013;14:133 https:\/\/doi.org\/10.1186\/1471-2369-14-133.","journal-title":"BMC Nephrol"},{"key":"957_CR40","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/ki.2009.502","volume":"77","author":"R Murugan","year":"2010","unstructured":"Murugan R, Karajala-Subramanyam V, Lee M, Yende S, Kong L, Carter M, et al. Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int. 2010;77:527\u201335. https:\/\/doi.org\/10.1038\/ki.2009.502.","journal-title":"Kidney Int"},{"key":"957_CR41","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3390\/pathogens12111346","volume":"12","author":"M Karasi\u0144ski","year":"2023","unstructured":"Karasi\u0144ski M, Wnorowska U, Durna\u015b B, Kr\u00f3l G, Daniluk T, Sk\u0142odowski K, et al. Ceragenins and ceragenin-based core-shell nanosystems as new antibacterial agents against Gram-negative rods causing nosocomial infections. Pathogens. 2023;12:1346 https:\/\/doi.org\/10.3390\/pathogens12111346.","journal-title":"Pathogens"},{"key":"957_CR42","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3390\/ph16121643","volume":"16","author":"M Hacioglu","year":"2023","unstructured":"Hacioglu M, Yilmaz FN, Oyardi O, Bozkurt Guzel C, Inan N, Savage P, et al. Antimicrobial activity of Ceragenins against vancomycin-susceptible and -resistant Enterococcus spp. Pharmaceuticals. 2023;16:1643 https:\/\/doi.org\/10.3390\/ph16121643.","journal-title":"Pharmaceuticals"},{"key":"957_CR43","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12951-019-0566-z","volume":"18","author":"U Wnorowska","year":"2020","unstructured":"Wnorowska U, Fiedoruk K, Piktel E, Prasad SV, Sulik M, Janion M, et al. Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools. J Nanobiotechnol. 2020;18:172 https:\/\/doi.org\/10.1186\/s12951-019-0566-z.","journal-title":"J Nanobiotechnol"},{"key":"957_CR44","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1053\/j.gastro.2018.01.026","volume":"154","author":"J Wang","year":"2018","unstructured":"Wang J, Ghali S, Xu C, Mussatto CC, Ortiz C, Lee EC, et al. Ceragenin CSA13 reduces Clostridium difficile infection in mice by modulating the intestinal microbiome and metabolites. Gastroenterology. 2018;154:1737\u201350. https:\/\/doi.org\/10.1053\/j.gastro.2018.01.026.","journal-title":"Gastroenterology"},{"key":"957_CR45","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2194444","volume":"45","author":"D Chen","year":"2023","unstructured":"Chen D, Jiang L, Tan Y, Zhao J, Huang W, Pan B, et al. Serum cystatin C within 24\u2009h after admission: a potential predictor for acute kidney injury in Chinese patients with community-acquired pneumonia. Ren Fail. 2023;45:2194444. https:\/\/doi.org\/10.1080\/0886022X.2023.2194444.","journal-title":"Ren Fail"},{"key":"957_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1292\/jvms.12-0154","volume":"75","author":"Y Kimoto","year":"2013","unstructured":"Kimoto Y, Nishinohara M, Sugiyama A, Haruna A, Takeuchi T. Protective effect of lactoferrin on Cisplatin-induced nephrotoxicity in rats. J Vet Med Sci. 2013;75:159\u201364. https:\/\/doi.org\/10.1292\/jvms.12-0154.","journal-title":"J Vet Med Sci"},{"key":"957_CR47","doi-asserted-by":"publisher","first-page":"e0151486","DOI":"10.1371\/journal.pone.0151486","volume":"11","author":"R Hegazy","year":"2016","unstructured":"Hegazy R, Salama A, Mansour D, Hassan A. Renoprotective effect of lactoferrin against chromium-induced acute kidney injury in rats: involvement of IL-18 and IGF-1 inhibition. PLoS One. 2016;11:e0151486 https:\/\/doi.org\/10.1371\/journal.pone.0151486.","journal-title":"PLoS One"},{"key":"957_CR48","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.kint.2025.05.030","volume":"108","author":"Q Xu","year":"2025","unstructured":"Xu Q, Li ZL, Zhang YL, Wu M, Shen A, Tang T, et al. Kidney hepcidin protects the collecting duct against ferroptosis in ischemia\/reperfusion-induced acute kidney injury. Kidney Int. 2025;108:394\u2013410. https:\/\/doi.org\/10.1016\/j.kint.2025.05.030.","journal-title":"Kidney Int"},{"key":"957_CR49","first-page":"3402","volume":"12","author":"G Xie","year":"2020","unstructured":"Xie G, Liu S, Zhang Q, Zhang W, Zhu L, Zhang Y, et al. The effect of hepcidin in rats with renal ischemia\/reperfusion injury. Am J Transl Res. 2020;12:3402\u201311.","journal-title":"Am J Transl Res"},{"key":"957_CR50","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1111\/bph.14998","volume":"177","author":"LL Pan","year":"2020","unstructured":"Pan LL, Liang W, Ren Z, Li C, Chen Y, Niu W, et al. Cathelicidin-related antimicrobial peptide protects against ischaemia-reperfusion-induced acute kidney injury in mice. Br J Pharm. 2020;177:2726\u201342. https:\/\/doi.org\/10.1111\/bph.14998.","journal-title":"Br J Pharm"},{"key":"957_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-024-01301-6","volume":"14","author":"T Iba","year":"2024","unstructured":"Iba T, Maier CL, Helms J, Ferrer R, Thachil J, Levy J, et al. Managing sepsis and septic shock in an endothelial glycocalyx-friendly way: from the viewpoint of surviving sepsis campaign guidelines. Ann Intensive Care. 2024;14:64. https:\/\/doi.org\/10.1186\/s13613-024-01301-6.","journal-title":"Ann Intensive Care"},{"key":"957_CR52","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fimmu.2015.00261","volume":"6","author":"MK Cowman","year":"2015","unstructured":"Cowman MK, Lee HG, Schwertfeger KL, McCarthy JB, Turley E. The content and size of hyaluronan in biological fluids and tissues. Front Immunol. 2015;6:261 https:\/\/doi.org\/10.3389\/fimmu.2015.00261.","journal-title":"Front Immunol"},{"key":"957_CR53","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ajpath.2019.11.016","volume":"190","author":"S Dogn\u00e9","year":"2020","unstructured":"Dogn\u00e9 S, Flamion B. Endothelial glycocalyx impairment in disease: focus on hyaluronan shedding. Am J Pathol. 2020;190:768\u201380. https:\/\/doi.org\/10.1016\/j.ajpath.2019.11.016.","journal-title":"Am J Pathol"},{"key":"957_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/712507","volume":"2015","author":"ME Lauer","year":"2015","unstructured":"Lauer ME, Dweik RA, Garantziotis S, Aronica MA. The rise and fall of hyaluronan in respiratory diseases. Int J Cell Biol. 2015;2015:712507. https:\/\/doi.org\/10.1155\/2015\/712507.","journal-title":"Int J Cell Biol"},{"key":"957_CR55","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ccc.2020.11.010","volume":"37","author":"CL Manrique-Caballero","year":"2021","unstructured":"Manrique-Caballero CL, Del Rio-Pertuz G, Gomez H. Sepsis-associated acute kidney injury. Crit Care Clin. 2021;37:279\u2013301. https:\/\/doi.org\/10.1016\/j.ccc.2020.11.010.","journal-title":"Crit Care Clin"},{"key":"957_CR56","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3390\/antiox10020325","volume":"10","author":"AE Bulboac\u0103","year":"2021","unstructured":"Bulboac\u0103 AE, Porfire A, Bolboac\u0103 SD, Nicula CA, Fe\u0219til\u0103 DG, Roman A, et al. Protective effects of liposomal curcumin on oxidative stress\/antioxidant imbalance, metalloproteinases 2 and 9, histological changes and renal function in experimental nephrotoxicity induced by gentamicin. Antioxidants. 2021;10:325 https:\/\/doi.org\/10.3390\/antiox10020325.","journal-title":"Antioxidants"},{"key":"957_CR57","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1827296","volume":"2021","author":"J Ismy","year":"2021","unstructured":"Ismy J, Syukri M, Emril DR, Sekarwana N, Ismy J, Suhanda R. The effect of superoxide dismutase on inhibition of acute kidney injury induced by sepsis based on kidney tissue histology and murine sepsis score. Sci World J. 2021;2021:1827296. https:\/\/doi.org\/10.1155\/2021\/1827296.","journal-title":"Sci World J"},{"key":"957_CR58","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/ph17020204","volume":"17","author":"M Czarnowski","year":"2024","unstructured":"Czarnowski M, S\u0142owi\u0144ska M, Sawieljew M, et al. Efficacy of ceragenins in controlling the growth of oral microorganisms: implications for oral hygiene management. Pharmaceuticals. 2024;17:204 https:\/\/doi.org\/10.3390\/ph17020204.","journal-title":"Pharmaceuticals"},{"key":"957_CR59","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/ph17020204","volume":"23","author":"MM Hashemi","year":"2018","unstructured":"Hashemi MM, Holden BS, Taylor MF, Wnorowska U, Daniluk T, Kr\u00f3l G, et al. Antibacterial and antifungal activities of poloxamer micelles containing ceragenin CSA-131 on ciliated tissues. Molecules. 2018;23:596 https:\/\/doi.org\/10.3390\/ph17020204.","journal-title":"Molecules"},{"key":"957_CR60","doi-asserted-by":"publisher","first-page":"e076720","DOI":"10.1136\/bmjopen-2023-076720","volume":"14","author":"NE Symonds","year":"2024","unstructured":"Symonds NE, Meng EX, Boyd JG, Boyd T, Day A, Hobbs H, et al. Ceragenin-coated endotracheal tubes for the reduction of ventilator-associated pneumonia: a prospective, longitudinal, cross-over, interrupted time, implementation study protocol (CEASE VAP study). BMJ Open. 2024;14:e076720 https:\/\/doi.org\/10.1136\/bmjopen-2023-076720.","journal-title":"BMJ Open"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-026-00957-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-026-00957-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-026-00957-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:02:02Z","timestamp":1793055722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-026-00957-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["957"],"URL":"https:\/\/doi.org\/10.1038\/s41429-026-00957-5","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"12 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have declared any potential conflicts of interest, reviewed the journal\u2019s conflict of interest policy. PBS is a paid consultant for N8 Medical, Inc.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}